NEW YORK (
) is trading at unusually high volume Thursday with 5.3 million shares changing hands. It is currently at 6.7 times its average daily volume and trading down $8.56 (-20.6%) at $32.89 as of 10:06 a.m. ET.
Salix has a market cap of $2.5 billion and is part of the
industry. Shares are down 11.7% year to date as of the close of trading on Wednesday.
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States.
TheStreet Ratings rates Salix as hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full
See all heavy volume stocks in our
or get investment ideas from our